Industry4 min read
Elecoglipron: AstraZeneca's Oral GLP-1 at ADA 2026
AstraZeneca's oral GLP-1 elecoglipron hit Phase 2b endpoints in VISTA and SOLSTICE. Full weight-loss data drops at ADA June 8. What it means for buyers.
Peptide Industry News
Brand launches, primer pieces, broader coverage.
Daily Peptide News
New articles delivered to your inbox every morning. Free.
Industry News
Industry6 min read
CagriSema Diabetes Data Debuts at ADA 2026
Novo's amylin/GLP-1 combo unveils first REIMAGINE diabetes results June 7 — 14.2% weight loss, 1.91% A1C drop. What it means for buyers.
Industry6 min read
Pep19: Peptide Cuts Visceral Fat 17%, No GLP-1
Pep19 cut visceral fat 17% and improved sleep in a 60-day trial — without GLP-1. A CB1 inverse-agonist peptide now sold as Nutroslim. What the data shows.
Industry7 min read
Do GH Peptides Desensitize the Pituitary?
Community protocols cycle 8 weeks on, 8 off to avoid desensitization. The trial data tells a more nuanced story — by peptide and by receptor.
Industry5 min read
Why GLP-1 Weight Loss Stalls: NIH Finds the Mechanism
NIH Nature Metabolism study: semaglutide plateaus happen because hindbrain neurons shut down cAMP signaling. PDE4 inhibitors may break it.
Industry4 min read
VC-Funded Peptide Startups Race to Build Before FDA Rules
Venture-backed startups raised $22M+ betting on peptide legalization this summer. Who they are, what they sell, and what it means for buyers.
Industry5 min read
GLP-1s Cut Cancer Metastasis Risk Up to 50%: ASCO Data
ASCO 2026 data: semaglutide and liraglutide users had 36-50% lower metastasis rates across lung, breast, colorectal, and liver cancers. The buyer breakdown.
Industry8 min read
What Is Bacteriostatic Water? Uses, Safety & Storage
One ingredient separates bacteriostatic water from sterile water — and that ingredient is the entire reason multi-dose peptide vials work.
Industry7 min read
Can You Make Bacteriostatic Water at Home? Risks
The DIY recipe is simple. The risks aren't. Why homemade bac water fails sterility, concentration, and pyrogen tests that take 30 seconds to buy around.
Industry5 min read
Teens Injecting Peptides: The Looksmaxxing Safety Crisis
Teen peptide injection rates are surging via looksmaxxing culture. Contamination data, organ-damage risks, and what COA-verified sourcing actually looks like.
Industry6 min read
GLP-1s Cut Heart Attack Risk 13% Across 91,490 Patients
Largest GLP-1 cardiovascular meta-analysis yet — 11 RCTs, 91,490 patients, 2.7-year follow-up. Semaglutide and liraglutide lead. What it means for you.
Industry5 min read
EASO Now Ranks Tirzepatide Above Semaglutide
Europe's top obesity body updated its algorithm May 12 — tirzepatide leads for weight loss, semaglutide for liver fibrosis. What it means for buyers.
Industry7 min read
MariTide Switch Trial: From Weekly GLP-1 to Monthly
Amgen's 300-patient MARITIME-Switch trial tests transitioning from weekly semaglutide or tirzepatide to MariTide every 8 weeks or quarterly.
Industry4 min read
What Are Peptides? How They Work in 2026
Peptides are amino acid chains that signal specific receptors. Key categories: growth hormone, metabolic, healing, and cognitive.
Industry14 min read
Peptide Stacking: 13 Best Combos & Doses
Not all stacks are equal — 3 combos stand out for synergy. 13 stacks with exact doses, timing, and which combos to avoid.
Industry12 min read
How Peptides Work: 4 Key Mechanisms
GH release, mitochondrial repair, metabolic signaling, and immune modulation — four pathways that explain every peptide.
Industry8 min read
FDA Fast-Tracks Liraglutide Knee Injection for OA
FDA gave 4P004 — intra-articular liraglutide for knee osteoarthritis — Fast Track in April. What it means for GLP-1 buyers and OA patients.
Industry9 min read
Tirzepatide Loses More Muscle Than Semaglutide: 670k Data
New nference preprint of 670,422 GLP-1 users shows tirzepatide patients lose 2% more lean mass at 12 months. Depletive metabotype hits 10.3%.